Home › Funds › AIGH Capital Management LLC › QNRX
AIGH Capital Management LLC position in QNRX
QUOIN PHARMACEUTICALS ADR · Health Care
AIGH Capital Management LLC reported holding 236,234 shares of QNRX (QUOIN PHARMACEUTICALS ADR) in its Q3 2026 13F filing — a position valued at US$1.1M, representing 0.11% of its reported portfolio and ranking #42 among its reported holdings. AIGH Capital Management LLC has disclosed QNRX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How AIGH Capital Management LLC's QNRX position evolved
AIGH Capital Management LLC first disclosed a stake in QNRX in Q4 2025 at 49,323 shares (US$712K). The position peaked in Q3 2026 at 236,234 shares, worth US$1.1M. Across 4 filings, AIGH Capital Management LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 236,234 shares valued at US$1.1M — an increase of 166,234 shares quarter over quarter.. Notable position changes include a 37% increase in Q2 2026 (shares fell 6% over the following quarter), a 237% increase in Q3 2026 (shares fell 16% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 49.32K | $711.73K | New |
| Q1 2026 | 51.00K | $336.60K | Add |
| Q2 2026 | 70.00K | $338.80K | Add |
| Q3 2026 | 236.23K | $1.08M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About QNRX and 13F data
QNRX (QUOIN PHARMACEUTICALS ADR) is a Health Care company. 21 other funds we track also report a position in QNRX — the largest reported positions include Dauntless Investment Group, LLC (US$1.0M), Stonepine Capital Management, LLC (US$966K), Velan Capital Investment Management LP (US$157K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding QNRX
- Dauntless Investment Group, LLC 214.99K sh · $1.04M · Q2 2026
- Stonepine Capital Management, LLC 199.49K sh · $965.51K · Q2 2026
- Velan Capital Investment Management LP 32.37K sh · $156.68K · Q2 2026
More on AIGH Capital Management LLC
FAQ
How long has AIGH Capital Management LLC held QNRX?
AIGH Capital Management LLC has disclosed QNRX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is AIGH Capital Management LLC's current position in QNRX?
As of Q3 2026, AIGH Capital Management LLC holds 236.23K shares of QNRX (QUOIN PHARMACEUTICALS ADR), valued at $1.08M, representing 0.11% of its reported portfolio and ranking #42.
Has AIGH Capital Management LLC been buying or selling QNRX?
In the latest 13F filing (Q3 2026), AIGH Capital Management LLC increased its position in QNRX. The position peaked in Q3 2026 at 236.23K shares.
Which other funds hold QNRX?
Other major institutional holders of QNRX include Dauntless Investment Group, LLC, Stonepine Capital Management, LLC, Velan Capital Investment Management LP, among 21 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.